Literature DB >> 14595441

Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1).

Koki Yamada1, Caroline Andrews, Wai-Man Chan, Craig A McKeown, Adriano Magli, Teresa de Berardinis, Anat Loewenstein, Moshe Lazar, Michael O'Keefe, Robert Letson, Arnold London, Mark Ruttum, Naomichi Matsumoto, Nakamichi Saito, Lisa Morris, Monte Del Monte, Roger H Johnson, Eiichiro Uyama, Willem A Houtman, Berendina de Vries, Thomas J Carlow, Blaine L Hart, Nicolas Krawiecki, John Shoffner, Marlene C Vogel, James Katowitz, Scott M Goldstein, Alex V Levin, Emin C Sener, Banu T Ozturk, A Nurten Akarsu, Michael C Brodsky, Frank Hanisch, Robert P Cruse, Alina A Zubcov, Richard M Robb, Peter Roggenkäemper, Irene Gottlob, Lionel Kowal, Ravi Battu, Elias I Traboulsi, Piergiorgio Franceschini, Anna Newlin, Joseph L Demer, Elizabeth C Engle.   

Abstract

Congenital fibrosis of the extraocular muscles type 1 (CFEOM1; OMIM #135700) is an autosomal dominant strabismus disorder associated with defects of the oculomotor nerve. We show that individuals with CFEOM1 harbor heterozygous missense mutations in a kinesin motor protein encoded by KIF21A. We identified six different mutations in 44 of 45 probands. The primary mutational hotspots are in the stalk domain, highlighting an important new role for KIF21A and its stalk in the formation of the oculomotor axis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595441     DOI: 10.1038/ng1261

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  84 in total

Review 1.  [Congenital fibrosis of extraocular muscles (CFEOM) and other phenotypes of congenital cranial dysinnervation syndromes (CCDD)].

Authors:  Frank Hanisch; Viktoria Bau; Stephan Zierz
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

Review 2.  The genetics of strabismus.

Authors:  M Michaelides; A T Moore
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

3.  Cerebellar atrophy in congenital fibrosis of the extraocular muscles type 1.

Authors:  Roberto Di Fabio; Giovanna Comanducci; Francesca Piccolo; Filippo Maria Santorelli; Teresa De Berardinis; Alessandra Tessa; Umberto Sabatini; Francesco Pierelli; Carlo Casali
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

4.  Gillies Lecture: ocular motility in a time of paradigm shift.

Authors:  Joseph L Demer
Journal:  Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 4.207

Review 5.  The genetic basis of incomitant strabismus: consolidation of the current knowledge of the genetic foundations of disease.

Authors:  Carolyn P Graeber; David G Hunter; Elizabeth C Engle
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

6.  Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles.

Authors:  Satoko Shimizu; Akira Okinaga; Toshio Maruo
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

7.  Magnetic resonance imaging of the endophenotype of a novel familial Möbius-like syndrome.

Authors:  Sean Dumars; Caroline Andrews; Wai-Man Chan; Elizabeth C Engle; Joseph L Demer
Journal:  J AAPOS       Date:  2008-05-02       Impact factor: 1.220

Review 8.  Kinesin superfamily motor proteins and intracellular transport.

Authors:  Nobutaka Hirokawa; Yasuko Noda; Yosuke Tanaka; Shinsuke Niwa
Journal:  Nat Rev Mol Cell Biol       Date:  2009-10       Impact factor: 94.444

9.  Structural basis for the recognition of kinesin family member 21A (KIF21A) by the ankyrin domains of KANK1 and KANK2 proteins.

Authors:  Qiong Guo; Shanhui Liao; Zhongliang Zhu; Yue Li; Fudong Li; Chao Xu
Journal:  J Biol Chem       Date:  2017-11-28       Impact factor: 5.157

10.  Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements.

Authors:  Elias I Traboulsi
Journal:  Trans Am Ophthalmol Soc       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.